A new approach to weight loss research is challenging one of the biggest assumptions behind popular weight loss drugs: Are GLP-1s actually needed to achieve weight loss?

In a new study published April 15 in the journal Molecular Metabolism, researchers tested a drug that targets two other hormones: GIP and glucagon. 

Th... Full Page

A growing number of younger adults are dying from colon cancer, but the increase isn’t affecting everyone in the same way.

New research, published April 16 in JAMA Oncology, shows the rise in colon cancer deaths is happening mostly among adults without a four-year college degree. That suggests social and economic factors cou... Full Page

The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized medications made by compounding pharmacies.

Peptides are small chains of amino acids that are marketed for a wide range of uses, including treating wounds, obesity, insomnia and inflammatory conditions.

An FDA advisor... Full Page

Most people would want to take a blood test that can assess their risk of Alzheimer’s disease, rather than remain anxious about their odds, a new study says.

About 85% of primary care patients said they’d take a blood test that looks for the toxic proteins linked to Alzheimer’s, according to a report published April 15 in... Full Page

Reaching for the salt shaker could have long-lasting implications for your memory and brain health, a new study says.

Higher sodium intake appears to affect episodic memory, the type of memory used to recall personal experiences and specific events from your past, researchers report in the June issue of the journal Neurobiology of Agin... Full Page